- Home
- LPTX vs GGR Comparison
LPTX vs GGR Comparison
Compare LPTX & GGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- GGR
- Stock Information
- Founded
- LPTX 2011
- GGR 2011
- Country
- LPTX United States
- GGR Taiwan
- Employees
- LPTX N/A
- GGR N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- GGR Auto Manufacturing
- Sector
- LPTX Health Care
- GGR Consumer Discretionary
- Exchange
- LPTX Nasdaq
- GGR Nasdaq
- Market Cap
- LPTX 119.6M
- GGR 114.3M
- IPO Year
- LPTX N/A
- GGR N/A
- Fundamental
- Price
- LPTX $0.38
- GGR $0.25
- Analyst Decision
- LPTX Buy
- GGR Hold
- Analyst Count
- LPTX 2
- GGR 2
- Target Price
- LPTX $8.00
- GGR $0.50
- AVG Volume (30 Days)
- LPTX 321.1K
- GGR 318.1K
- Earning Date
- LPTX 08-11-2025
- GGR 08-14-2025
- Dividend Yield
- LPTX N/A
- GGR N/A
- EPS Growth
- LPTX N/A
- GGR N/A
- EPS
- LPTX N/A
- GGR N/A
- Revenue
- LPTX N/A
- GGR $304,551,000.00
- Revenue This Year
- LPTX N/A
- GGR N/A
- Revenue Next Year
- LPTX N/A
- GGR $5.00
- P/E Ratio
- LPTX N/A
- GGR N/A
- Revenue Growth
- LPTX N/A
- GGR N/A
- 52 Week Low
- LPTX $0.22
- GGR $0.19
- 52 Week High
- LPTX $4.79
- GGR $1.76
- Technical
- Relative Strength Index (RSI)
- LPTX 46.09
- GGR 42.72
- Support Level
- LPTX $0.38
- GGR $0.25
- Resistance Level
- LPTX $0.44
- GGR $0.27
- Average True Range (ATR)
- LPTX 0.04
- GGR 0.01
- MACD
- LPTX -0.00
- GGR 0.00
- Stochastic Oscillator
- LPTX 22.52
- GGR 11.15
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .
About GGR Gogoro Inc.
Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.